Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Covered self-expanding metal stents for the management of common bile duct stones.

Hartery K, Lee CS, Doherty GA, Murray FE, Cullen G, Patchett SE, Mulcahy HE.

Gastrointest Endosc. 2017 Jan;85(1):181-186. doi: 10.1016/j.gie.2016.05.038. Epub 2016 Jun 1.

PMID:
27262891
2.

Common bile duct duplication: double bile ducts, double trouble.

Chin JL, Sengupta S, Morrin MM, Murray FE, Patchett SE.

Gastrointest Endosc. 2017 Apr;85(4):855-856. doi: 10.1016/j.gie.2016.05.005. Epub 2016 May 11. No abstract available.

PMID:
27179690
3.

The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.

Kelly OB, Dillane C, Patchett SE, Harewood GC, Murray FE.

Dig Dis Sci. 2015 Aug;60(8):2280-6. doi: 10.1007/s10620-015-3642-8. Epub 2015 Apr 4.

PMID:
25840918
4.

Investors prefer entrepreneurial ventures pitched by attractive men.

Brooks AW, Huang L, Kearney SW, Murray FE.

Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4427-31. doi: 10.1073/pnas.1321202111. Epub 2014 Mar 10.

5.

Band ligation of gastric antral vascular ectasia is a safe and effective endoscopic treatment.

Keohane J, Berro W, Harewood GC, Murray FE, Patchett SE.

Dig Endosc. 2013 Jul;25(4):392-6. doi: 10.1111/j.1443-1661.2012.01410.x. Epub 2012 Dec 17.

PMID:
23808945
6.

Does the cost of care differ for patients with fee-for-service vs. capitation of payment? A case-control study in gastroenterology.

Slattery E, Clancy KX, Harewood GC, Murray FE, Patchett S.

Ir J Med Sci. 2013 Dec;182(4):669-72. doi: 10.1007/s11845-013-0951-9. Epub 2013 Apr 19.

PMID:
23605087
7.

Ursodeoxycholic acid attenuates colonic epithelial secretory function.

Kelly OB, Mroz MS, Ward JB, Colliva C, Scharl M, Pellicciari R, Gilmer JF, Fallon PG, Hofmann AF, Roda A, Murray FE, Keely SJ.

J Physiol. 2013 May 1;591(9):2307-18. doi: 10.1113/jphysiol.2013.252544. Epub 2013 Mar 18.

8.

Re-infection following sustained virological response with a different hepatitis C virus genotype: implications for infection control policy.

O'Shaughnessy MM, O'Regan JA, Murray FE, Connell JA, Duffy MP, Francis VM, Dwyer S, Thornton LM, Conlon PJ.

Clin Kidney J. 2012 Jun;5(3):250-3. doi: 10.1093/ckj/sfs040. Epub 2012 Apr 18.

9.

Quality of colonoscopy performance among gastroenterology and surgical trainees: a need for common training standards for all trainees?

Leyden JE, Doherty GA, Hanley A, McNamara DA, Shields C, Leader M, Murray FE, Patchett SE, Harewood GC.

Endoscopy. 2011 Nov;43(11):935-40. doi: 10.1055/s-0030-1256633. Epub 2011 Oct 13.

PMID:
21997723
10.

Mesalazine-induced bronchiolitis obliterans organizing pneumonia (BOOP) in a patient with ulcerative colitis and primary sclerosing cholangitis.

Kevans D, Greene J, Galvin L, Morgan R, Murray FE.

Inflamm Bowel Dis. 2011 Oct;17(10):E137-8. doi: 10.1002/ibd.21819. Epub 2011 Jul 14. No abstract available.

PMID:
21761513
11.

Inter-endoscopist agreement in diagnosis of Barrett's oesophagus.

Doherty GA, Cheriyan DG, Leyden JE, O'Dowd JF, Murray FE, Patchett SE.

Frontline Gastroenterol. 2011 Jul;2(3):162-167. doi: 10.1136/fg.2010.001529. Epub 2011 Mar 20.

12.

Prevalence and progress of joint symptoms in hereditary hemochromatosis and symptomatic response to venesection.

Harty LC, Lai D, Connor S, Dunne A, Ali M, Ryan J, O'Connell PG, Murray FE.

J Clin Rheumatol. 2011 Jun;17(4):220-2. doi: 10.1097/RHU.0b013e31821c7ce1. No abstract available.

PMID:
21617548
13.

Delayed acute hospital discharge and healthcare-associated infection: the forgotten risk factor.

McNicholas S, Andrews C, Boland K, Shields M, Doherty GA, Murray FE, Smyth EG, Humphreys H, Fitzpatrick F.

J Hosp Infect. 2011 Jun;78(2):157-8. doi: 10.1016/j.jhin.2011.03.001. Epub 2011 Apr 16. No abstract available.

PMID:
21497945
14.

Clinical presentation of adult coeliac disease.

Tajuddin T, Razif S, Dhar R, Thorne J, Murray FE.

Ir Med J. 2011 Jan;104(1):20-2.

PMID:
21387881
15.

Assessment of service delays and impact on bed utilisation in a major teaching hospital.

Conway R, Murray FE.

Ir J Med Sci. 2011 Jun;180(2):533-5. doi: 10.1007/s11845-010-0648-2. Epub 2010 Dec 14.

PMID:
21153929
16.

Utilization of resource leveling to optimize ERCP efficiency.

Hendrick LM, Harewood GC, Patchett SE, Murray FE.

Ir J Med Sci. 2011 Mar;180(1):143-8. doi: 10.1007/s11845-010-0570-7. Epub 2010 Sep 11.

PMID:
20835852
17.

Approach to biliary imaging amongst consultant and specialist registrars in gastroenterology in a national setting.

Murray T, Murray FE, Donnellan F.

Ir J Med Sci. 2010 Dec;179(4):539-43. doi: 10.1007/s11845-010-0529-8. Epub 2010 Jul 27.

PMID:
20661781
18.

Perceptions of medication safety among patients with inflammatory bowel disease.

Cullen G, Donnellan F, Long S, Forry M, Murray FE.

Scand J Gastroenterol. 2010 Sep;45(9):1076-83. doi: 10.3109/00365521.2010.490595.

PMID:
20459367
19.

Economic impact of prescreening on gastroenterology outpatient clinic practice.

Donnellan F, Harewood GC, Cagney D, Basri F, Patchett SE, Murray FE.

J Clin Gastroenterol. 2010 Apr;44(4):e76-9. doi: 10.1097/MCG.0b013e3181be9a24.

PMID:
20305467
20.

What's in the cin bin?

Donnellan F, Pankratieva E, Murray FE.

J Hosp Infect. 2010 Jul;75(3):246. doi: 10.1016/j.jhin.2009.11.014. Epub 2010 Mar 17. No abstract available.

PMID:
20299124
21.

Efficacy and safety of colonic stenting for malignant disease in the elderly.

Donnellan F, Cullen G, Cagney D, O'Halloran P, Harewood GC, Murray FE, Patchett SE.

Int J Colorectal Dis. 2010 Jun;25(6):747-50. doi: 10.1007/s00384-010-0917-6. Epub 2010 Mar 6.

PMID:
20213457
22.

JNK mitogen-activated protein kinase limits calcium-dependent chloride secretion across colonic epithelial cells.

Donnellan F, Keating N, Geoghegan P, Murray FE, Harvey BJ, Keely SJ.

Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G37-44. doi: 10.1152/ajpgi.00202.2009. Epub 2009 Oct 29.

23.

Bid and calpains cooperate to trigger oxaliplatin-induced apoptosis of cervical carcinoma HeLa cells.

Anguissola S, Köhler B, O'Byrne R, Düssmann H, Cannon MD, Murray FE, Concannon CG, Rehm M, Kögel D, Prehn JH.

Mol Pharmacol. 2009 Nov;76(5):998-1010. doi: 10.1124/mol.109.058156. Epub 2009 Aug 27.

PMID:
19713356
24.

Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.

Doherty GA, Byrne SM, Austin SC, Scully GM, Sadlier DM, Neilan TG, Kay EW, Murray FE, Fitzgerald DJ.

Br J Cancer. 2009 Aug 4;101(3):483-91. doi: 10.1038/sj.bjc.6605144.

25.

Co-prescription of gastro-protectants in hospitalized patients: an analysis of what we do and what we think we do.

Doherty GA, Cannon MD, Lynch KM, Ayoubi KZ, Harewood GC, Patchett SE, Murray FE.

J Clin Gastroenterol. 2010 Mar;44(3):e51-6. doi: 10.1097/MCG.0b013e3181a9f43b.

PMID:
19609216
26.

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.

Doherty GA, Byrne SM, Molloy ES, Malhotra V, Austin SC, Kay EW, Murray FE, Fitzgerald DJ.

BMC Cancer. 2009 Jun 26;9:207. doi: 10.1186/1471-2407-9-207.

27.

New-onset ulcerative colitis in a patient treated with the anti-CD11a monoclonal antibody efalizumab.

Donnellan F, Cullen G, Murray FE.

Am J Gastroenterol. 2009 Apr;104(4):1055. doi: 10.1038/ajg.2008.137. Epub 2009 Mar 3. No abstract available.

PMID:
19259079
28.

Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?

Doherty GA, Murray FE.

Expert Opin Ther Targets. 2009 Feb;13(2):209-18. doi: 10.1517/14728220802653631 . Review.

PMID:
19236238
29.

Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatment.

Manning DS, Sheehan KM, Byrne MF, Kay EW, Murray FE.

J Gastroenterol Hepatol. 2007 Oct;22(10):1633-7.

PMID:
17845691
30.

The effect of different strains of Helicobacter pylori on platelet aggregation.

Corcoran PA, Atherton JC, Kerrigan SW, Wadstrom T, Murray FE, Peek RM, Fitzgerald DJ, Cox DM, Byrne MF.

Can J Gastroenterol. 2007 Jun;21(6):367-70.

31.

Patients' knowledge of adverse reactions to current medications.

Cullen G, Kelly E, Murray FE.

Br J Clin Pharmacol. 2006 Aug;62(2):232-6.

32.

Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996-2001.

Smyth CM, Picha SB, Rathore O, Deasy J, Patchett SE, Murray FE.

Ir J Med Sci. 2005 Oct-Dec;174(4):28-32.

PMID:
16445157
33.

The importance of microbiological investigations, medications and artificial feeding in diarrhoea evaluation.

McErlean A, Kelly O, Bergin S, Patchett SE, Murray FE.

Ir J Med Sci. 2005 Jan-Mar;174(1):21-5.

PMID:
15868885
34.

Current management of corticosteroid-induced osteoporosis: variations in awareness and management.

Ryan JG, Morgan RK, Lavin PJ, Murray FE, O'Connell PG.

Ir J Med Sci. 2004 Jan-Mar;173(1):20-2.

PMID:
15732231
35.

Association between cyclooxygenase-2-expressing macrophages, ulceration and microvessel density in colorectal cancer.

Sheehan KM, Steele C, Sheahan K, O'Grady A, Leader MB, Murray FE, Kay EW.

Histopathology. 2005 Mar;46(3):287-95.

PMID:
15720414
36.

Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity.

Cahill RA, Sheehan KM, Scanlon RW, Murray FE, Kay EW, Redmond HP.

Br J Surg. 2004 Dec;91(12):1613-8.

PMID:
15505871
37.

Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.

Sheehan KM, Cahill RA, McGreal G, Steele C, Byrne MF, Kirwan WO, Kay EW, Fitzgerald DJ, Redmond HP, Murray FE.

Dig Liver Dis. 2004 Jun;36(6):392-7.

PMID:
15248379
38.

The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas.

Sheehan KM, O'Connell F, O'Grady A, Conroy RM, Leader MB, Byrne MF, Murray FE, Kay EW.

Eur J Gastroenterol Hepatol. 2004 Jun;16(6):619-25.

PMID:
15167166
39.

Combined terminal ileoscopy and biopsy is superior to small bowel follow-through in detecting terminal ileal pathology.

Byrne MF, Power DG, Keeling AN, Kay E, Murray FE, Patchett SE.

Dig Liver Dis. 2004 Feb;36(2):147-52.

PMID:
15002824
40.

The seroprevalence of Helicobacter pylori in an Irish university student population.

Sheehan KM, Byrne MF, Murray FE.

J Infect. 2004 Apr;48(3):283-4. No abstract available.

PMID:
15001309
41.

A prospective analysis of inpatient consultations to a gastroenterology service.

Bohra S, Byrne MF, Manning D, Smyth C, Patchett SE, Murray FE.

Ir Med J. 2003 Oct;96(9):263-5.

PMID:
14753578
42.

Cyclooxygenase-2 expression in stromal tumors of the gastrointestinal tract.

Sheehan KM, Sabah M, Cummins RJ, O'Grady A, Murray FE, Leader MB, Kay EW.

Hum Pathol. 2003 Dec;34(12):1242-6.

PMID:
14691908
43.

Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells.

Byrne MF, Murphy JF, Corcoran PA, Atherton JC, Sheehan KM, Cox D, Murray FE, Fitzgerald DJ.

Scand J Gastroenterol. 2003 Oct;38(10):1023-30.

PMID:
14621275
44.

Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation.

Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM.

Gastroenterology. 2003 Jun;124(7):1846-54.

PMID:
12806618
45.

Idiopathic cholangiopathy in a biliary cast syndrome necessitating liver transplantation following head trauma.

Byrne MF, Chong HI, O'Donovan D, Sheehan KM, Leader MB, Kay E, McCormick PA, Broe P, Murray FE.

Eur J Gastroenterol Hepatol. 2003 Apr;15(4):415-7. Erratum in: Eur J Gastroenterol Hepatol. 2003 Aug;15(8):939. McCormack Aiden [corrected to McCormick P Aiden].

PMID:
12655263
46.

Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.

Sheehan KM, O'Donovan DG, Fitzmaurice G, O'Grady A, O'Donoghue DP, Sheahan K, Byrne MF, Conroy RM, Kay EW, Murray FE.

Eur J Gastroenterol Hepatol. 2003 Apr;15(4):375-80.

PMID:
12655257
47.

Effect of H. pylori infection on the expression of cyclooxygenase-2 in human gastric mucosa.

Shah AA, Byrne MF, Cullen L, Walsh T, Fitzgerald DJ, Murray FE.

Prostaglandins Leukot Essent Fatty Acids. 2003 Jan;68(1):1-8.

PMID:
12538084
48.

Stimulation of adhesion molecule expression by Helicobacter pylori and increased neutrophil adhesion to human umbilical vein endothelial cells.

Byrne MF, Corcoran PA, Atherton JC, Sheehan KM, Murray FE, Fitzgerald DJ, Murphy JF.

FEBS Lett. 2002 Dec 18;532(3):411-4.

49.

Nonsteroidal anti-inflammatory drug-induced diaphragms and ulceration in the colon.

Byrne MF, McGuinness J, Smyth CM, Manning DS, Sheehan KM, Bohra SG, Patchett SE, Murray FE.

Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1265-9. Review.

PMID:
12439124
50.

Hepatitis C infection in plasmapheresis donors: an overlooked risk factor for transmission?

Smyth CM, Manning DS, Byrne MF, Murray FE.

Eur J Gastroenterol Hepatol. 2002 Aug;14(8):891-2.

PMID:
12172413

Supplemental Content

Loading ...
Support Center